ニュース
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
The FDA is forcing Pfizer and Moderna to expand warning labels about the risks of two forms of heart damage, myocarditis and ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning ...
The US Food and Drug Administration may limit Covid-19 boosters shots to high-risk groups from 2025; Pfizer reviewing proposal as agency seeks new trials, clearer risk labels for younger males ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...
7 日
ウォール・ストリート・ジャーナル日本版 on MSNファイザーのコロナワクチンで新疑惑、米下院委が調査米議員らは、製薬大手ファイザーが新型コロナワクチンの臨床試験(治験)結果の公表を2020年の米大統領選が終わるまで待ったかどうかを調査している。下院司法委員会の新たな書簡によると、ファイザー元社員の科学者が実験を「意図的に遅らせる」取り組みへの関与を認めたとする新たな疑惑が浮上した。
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...
8 時間
India Today on MSNCovid-19 vaccine rules may change from 2025: What you should knowThe FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under 65. Pfizer is reviewing the plan, while officials call for more evidence ...
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
9 時間on MSN
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする